SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-075701
Filing Date
2019-03-15
Accepted
2019-03-15 07:33:02
Documents
9
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d720292ddefa14a.htm DEFA14A 27636
2 GRAPHIC g720292img1.jpg GRAPHIC 12110
3 GRAPHIC g720292img2.jpg GRAPHIC 2686
4 GRAPHIC g720292img3.jpg GRAPHIC 11604
5 GRAPHIC g720292img4.jpg GRAPHIC 11534
6 GRAPHIC g720292img5.jpg GRAPHIC 3385
7 GRAPHIC g720292img6.jpg GRAPHIC 2753
8 GRAPHIC g720292img7.jpg GRAPHIC 8820
9 GRAPHIC g720292img8.jpg GRAPHIC 2494
  Complete submission text file 0001193125-19-075701.txt   106037
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 19682939
SIC: 2834 Pharmaceutical Preparations